Company Name:Medpace Holdings Inc.
CEO: August J. Troendle

Sector: Healthcare

Exchange: Nasdaq Global Select

Country: USA

Description: Medpace Holdings Inc is a clinical contract research organisation. It is engaged in providing scientifically-driven clinical research-based drug and medical device development services to the biotechnology, pharmaceutical and medical device industries.


Key numbers

Market Capitalization:2619381000
Shares Outstanding: 36030000
Float: 27577614.21
Next Earning Date:2020-03-04
TTm EPS: 2.6022
TTm Dividend Rate:
200 days moving average:66.92
50 days moving average: 78.39
One day percent Change: 2.28



2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2018-06-30, 2018-09-30, 2018-12-31, 2019-03-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,
2015-12-31, 2016-12-31, 2017-12-31, 2018-12-31,